Related Image: Baltimore LASIK Surgeon Roy Chuck, MD, PhD of the Wilmer Eye Institute at Johns Hopkins Lists with Trusted LASIK Surgeons |
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3... LUVOX(R) CR Approved and Launched - Screening C...al, PALO ALTO, Calif., May 13 Jazz,Pharmaceutica...l results for,the quarter ended March 31, 2008., ...8 were $14.6 million,compared to $14.1 million for...m oxybate oral solution) net sales for the first q...
...upport for Grassley-Kohl Bill Newest Addition to L... Agenda, INDIANAPOLIS, May 13 Today Eli Lilly a...the newly revised Physicians,Payments Sunshine Act...sley,(R-Iowa) and Herbert Kohl (D-Wisconsin). The ...y of payments to physicians by medical device,medi...
...AKE FOREST, Ill., May 13 Hospira, Inc.,(NYSE: HS...ion delivery,company, announced today that Barbara... board of directors. Bowles brings strong investme...p positions held at major,multinational consumer g...s. The addition of Bowles expands Hospira,s board ...
Other Biology Technology:Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 2Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 3Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 4Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 5Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 6Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 7Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 8Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians 2Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians 3Hospira Expands Board of Directors 2ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Rabbit Anti-ISOCITRATE DEHYDROGENASE Polyclonal Antibody, Unconjugated from AbD Serotec
... two highly efficient methods of identifying recom...consuming plasmid preparation. By using the large-...s to transfer partial colonies of E. coli bacteria...solutions provided by the kits and immediately run...
Biology Products: